Earnings per Share (Tables)

6 Months Ended

Jun. 27, 2025

Earnings Per Share [Abstract]

Schedule of Earnings per Share

The weighted-average number of shares outstanding used in the computations of basic and diluted income (loss) per share were as follows (in millions of shares):

	Three Months Ended		Six Months Ended
	June 27, 2025	June 28, 2024	June 27, 2025	June 28, 2024
Basic	19.7	19.7	19.7	19.7
Dilutive impact of restricted share units	0.4	—	—	—
Diluted	20.1	19.7	19.7	19.7

A net loss cannot be diluted. When a Company is in a net loss position, basic and diluted loss per share are the same. If the Company records net income, the denominator of a diluted earnings per share calculation will include both the weighted average number of shares outstanding and the number of common stock equivalents, if the inclusion of such common stock equivalents would be dilutive. Contingent value rights held by the Opioid Master Disbursement Trust II and outstanding equity awards that could potentially dilute per share amounts in the future were as follows (in millions of shares):

	Three Months Ended		Six Months Ended
	June 27, 2025	June 28, 2024	June 27, 2025	June 28, 2024
Potentially dilutive share amounts	1.4	1.8	1.7	1.8